The Traderszone Network

18 May, 2014 by The TZ Newswire Staff Comments Off on New Zealand Producer Price Index – Output (QoQ) came in at 0.9%, above expectations (0.7%) in 1Q

New Zealand Producer Price Index – Output (QoQ) came in at 0.9%, above expectations (0.7%) in 1Q

FXStreet.com (Barcelona) For more information, read our latest forex news.

For more information, read our latest forex news.

18 May, 2014 by The TZ Newswire Staff Comments Off on New Zealand Producer Price Index – Input (QoQ) came in at 1%, above forecasts (0.4%) in 1Q

New Zealand Producer Price Index – Input (QoQ) came in at 1%, above forecasts (0.4%) in 1Q

FXStreet.com (Barcelona) For more information, read our latest forex news.

For more information, read our latest forex news.

18 May, 2014 by The TZ Newswire Staff Comments Off on What Japan Teaches Us of China’s Quest for Resources

What Japan Teaches Us of China’s Quest for Resources

The Motley Fool’s Joel South interviews Michael Levi, co-author of “By All Means Necessary: How China’s Resource Quest is Changing the World,” about parallels between China’s resource crisis and other economies.

read more

18 May, 2014 by The TZ Newswire Staff Comments Off on Take A Dive In The "Dash For Trash" Waterfall With Goldman Sachs

Take A Dive In The "Dash For Trash" Waterfall With Goldman Sachs

As we have discussed numerous times, the dash-for-trash in US equities has been insatiable as any and every consequence of screwing up is slowly removed from capitalism (and capital markets). As Goldman’s David Kostin notes, companies with weak balance sheets have outperformed peers with strong balance sheets by 49 percentage points during the past two years (89% vs. 40%) with realized volatility of just 7%.

 

read more

18 May, 2014 by The TZ Newswire Staff Comments Off on Biotech of the Week: Ariad Pharmaceuticals, Inc.

Biotech of the Week: Ariad Pharmaceuticals, Inc.

After high hopes, it doesn’t look like Ariad Pharmaceuticals’ Iclusig will be able to compete with leukemia drugs from Novartis and Bristol-Myers Squibb.

read more